Brief: T2 Biosystems Announces Extension Of Multiyear Innovative Technology Contract With Vizient
28/12/2022 15:06
Dec 28 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS ANNOUNCES EXTENSION OF MULTIYEAR INNOVATIVE
TECHNOLOGY CONTRACT WITH VIZIENT, INC.
* T2 BIOSYSTEMS INC- ITS INNOVATIVE TECHNOLOGY CONTRACT WITH
VIZIENT, INC. HAS BEEN EXTENDED THROUGH MARCH 31, 2024
Source text for Eikon: ID:nGNX3t65SV
Further company coverage: TTOO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor